How Bone Age Is Used to Predict Your Child’s Adult Height

Bone age predicts adult height by comparing your child’s skeletal maturity to their chronological age, then applying that gap to established growth charts. A child whose bone age is 2 years behind their actual age likely has more growth remaining than peers the same size. Most pediatric endocrinologists in the United States use this method to generate height predictions accurate within roughly 1 to 2 inches for the majority of children.

What Bone Age Actually Measures

Bone age, sometimes called skeletal age, is a radiological measurement that reflects how mature a child’s skeleton is based on the development of growth plates, which are the soft cartilage zones near the ends of long bones where new bone tissue is produced. It does not measure how old a child is in years; it measures how far along their skeleton is in the process of hardening and closing those plates.

A single X-ray of the left hand and wrist is the standard method used across U.S. pediatric clinics. Radiologists count and compare the size, shape, and density of 29 bones in that image against reference atlases built from large population studies.

The hand and wrist are used specifically because they contain a high concentration of small bones, each of which matures on a slightly different schedule. This density of developmental information in a single small area makes the hand and wrist far more informative per square centimeter of X-ray than any other body region. The carpal bones, metacarpals, and phalanges all develop at measurably different rates, giving radiologists multiple independent data points within a single image.

The Greulich and Pyle Atlas: The Reference Standard

The Greulich and Pyle atlas, first published in 1950 and still widely used today, is a photographic reference collection of hand and wrist X-rays organized by age and sex. Radiologists place a child’s X-ray next to atlas images until they find the closest skeletal match, and that matching age becomes the recorded bone age.

A second commonly used method in U.S. pediatric radiology is the Tanner-Whitehouse method, a scoring system that assigns numerical points to each of 20 specific bones in the hand and wrist, then converts the total score into a bone age estimate. The Tanner-Whitehouse approach is considered more reproducible because it removes some of the subjective visual matching involved in the Greulich and Pyle comparison.

A third option gaining traction in U.S. academic medical centers is BoneXpert, an AI-assisted software platform that automates bone age measurement by analyzing the X-ray image algorithmically. Studies published in peer-reviewed radiology journals have shown BoneXpert produces readings with inter-observer variability that is significantly lower than manual atlas methods, making it particularly useful in high-volume pediatric radiology departments.

The FELS method, developed at the Fels Research Institute in Ohio and published in 1988, is a fourth approach that uses statistical regression modeling rather than atlas comparison or simple scoring. It generates a bone age estimate with a built-in confidence interval, making it one of the few methods that quantifies prediction uncertainty directly within the output. It is used more commonly in research settings than in routine clinical practice.

Growth Plates and Why Their Status Changes Everything

Growth plates, also called epiphyseal plates, are living cartilage tissue that fuses into solid bone as a child matures. Once a growth plate closes completely, that bone can no longer lengthen. The timing of closure is what makes bone age so clinically meaningful: a child with open growth plates still has height potential, while a child with closed plates has reached or nearly reached their final stature.

In girls, growth plates typically close between ages 14 and 16. In boys, closure generally occurs between 16 and 18. These are population averages; bone age testing reveals where any individual child actually sits within that range, regardless of their birth certificate age.

• Age Calculator – Find Exact Age in Years, Months, & Days by Date of Birth – AgeFinder.Org

The process of growth plate closure does not happen simultaneously across all bones. The small bones of the hand and wrist close earlier than the long bones of the legs, which is one reason hand and wrist X-rays remain useful even in adolescents approaching the end of their growth period. The distal radius, one of the last bones in the wrist to fuse completely, is a particularly reliable marker of near-complete skeletal maturity.

Growth velocity, meaning the number of centimeters or inches a child grows per year, is directly linked to growth plate biology. During infancy, growth velocity can reach 25 centimeters per year. It slows through childhood to approximately 5 to 6 centimeters per year before accelerating again during the pubertal growth spurt, which averages 8 to 12 centimeters per year at peak velocity. Once growth plates begin closing, velocity drops sharply and stops entirely at fusion.

Key Finding: A child who is 13 years old chronologically but has a bone age of 11 may still have 3 to 4 years of significant growth remaining, a difference that changes adult height predictions substantially.

The Stages of Puberty and Their Connection to Skeletal Timing

Puberty and bone age are inseparably linked because the sex hormones released during puberty, primarily estrogen in girls and testosterone in boys, are the primary biological drivers of both growth acceleration and growth plate closure. Understanding pubertal staging is therefore essential context for interpreting any bone age result.

Pediatricians in the United States use the Tanner staging system, developed by British pediatrician James Tanner in 1969, to classify pubertal development into 5 stages based on observable physical characteristics. Tanner stage 1 represents prepuberty, while Tanner stage 5 represents full adult maturity.

The relationship between Tanner stage and bone age is remarkably consistent across large population studies:

A child at Tanner stage 2 with a bone age consistent with stage 1 has more growth ahead than their peers at the same Tanner stage with an age-appropriate bone age. This intersection of pubertal staging and skeletal maturity is where the most clinically meaningful height predictions are generated.

How Pediatricians Turn a Bone Age Into a Height Prediction

Pediatricians and pediatric endocrinologists use bone age alongside several other data points to calculate a predicted adult height (PAH). The process is structured and relies on validated formulas rather than guesswork.

The Bayley-Pinneau Method

The Bayley-Pinneau tables, published in 1952, remain a cornerstone of height prediction in American pediatric practice. A child’s current height is divided by a percentage value found in the Bayley-Pinneau table that corresponds to their bone age and sex. The result is the predicted adult height.

For example: a girl who is 50 inches tall at a bone age of 9 years has completed approximately 77% of her adult height according to the Bayley-Pinneau tables. Dividing 50 by 0.77 yields a predicted adult height of roughly 65 inches, or 5 feet 5 inches.

The Bayley-Pinneau tables were developed from data collected as part of the Berkeley Growth Study, a longitudinal research project that tracked children from infancy through adulthood in Berkeley, California beginning in the 1920s. The tables are sex-specific and contain separate columns for children with accelerated, average, and delayed bone age to account for the different growth trajectories associated with early and late maturers.

The Mid-Parental Height Formula

Most U.S. pediatricians also calculate mid-parental height (MPH), which estimates the genetically expected height range for a child based on the heights of both biological parents. The formula differs by sex:

1. For boys: Add both parents’ heights in inches, add 5 inches, then divide by 2. The result is the mid-parental height with a target range of plus or minus 2 inches.
2. For girls: Add both parents’ heights in inches, subtract 5 inches, then divide by 2. The result is the mid-parental height with a target range of plus or minus 2 inches.

When a child’s bone-age-based predicted adult height falls well outside this mid-parental range, that discrepancy often triggers further evaluation.

The Roche-Wainer-Thissen Method

The Roche-Wainer-Thissen (RWT) method, developed in the 1970s and refined using data from the Fels Longitudinal Study in Ohio, takes a more comprehensive statistical approach to height prediction. It incorporates bone age, current height, current weight, and mid-parental height simultaneously into a regression equation rather than relying on a single table lookup.

Research comparing prediction methods has generally shown the RWT method produces slightly smaller prediction errors than Bayley-Pinneau alone, particularly in children who are significantly overweight or underweight, where weight-independent methods may be less accurate. Some U.S. pediatric endocrinology centers use RWT as a secondary check on Bayley-Pinneau estimates.

Khamis-Roche Method for Children Without Bone Age X-Rays

The Khamis-Roche method, published in 1994, is notable because it predicts adult height without requiring a bone age X-ray at all. It uses only current height, current weight, and mid-parental height to generate a prediction. While its accuracy is modestly lower than bone-age-based methods, it provides a useful screening estimate in situations where imaging is not immediately available or where minimizing radiation exposure is a priority. Many online pediatric height calculators used by U.S. families are based on the Khamis-Roche formula.

Normal Variation vs. a Signal Worth Investigating

A bone age that differs from chronological age by up to 2 years in either direction is typically within the range of normal variation for healthy children in the United States. This range simply reflects the natural spectrum of how quickly different children mature skeletally.

Bone age becomes clinically significant in the following situations:

• Bone age more than 2 years behind chronological age may suggest constitutional delay of growth and puberty, hypothyroidism, growth hormone deficiency, or other conditions affecting development.
• Bone age more than 2 years ahead of chronological age may indicate precocious puberty, meaning early puberty that begins before age 8 in girls and 9 in boys, congenital adrenal hyperplasia, or exposure to exogenous sex hormones.
• Predicted adult height more than 2 standard deviations below the mid-parental range warrants referral to a pediatric endocrinologist.
• Growth velocity below 4 centimeters per year in a school-age child, regardless of bone age, is a red flag that typically prompts further workup.

Important Note: Bone age X-rays expose children to a very small amount of radiation. The effective dose from a hand and wrist X-ray is approximately 0.001 millisieverts, which is less than a single day of natural background radiation exposure.

It is equally important to recognize what a bone age result alone cannot confirm. A delayed bone age is an observation, not a diagnosis. The same finding can result from constitutional growth delay, which requires no treatment and resolves naturally, or from growth hormone deficiency, which requires treatment to optimize adult height. The clinical workup that follows a bone age result is what determines the appropriate course of action.

Conditions That Shift Bone Age Significantly

Several medical diagnoses specifically alter the relationship between chronological age and bone age, and understanding these conditions is what makes bone age testing so valuable in clinical diagnosis.

Constitutional growth delay describes a pattern where a child grows slowly, has a bone age younger than their chronological age, but is otherwise healthy and simply matures on a later schedule. These children typically reach a normal adult height, just later than their peers. This distinction from pathological delay is one of the most important clinical judgments a pediatric endocrinologist must make, and bone age is central to that conversation.

Turner syndrome, a chromosomal condition affecting girls who have only one functional X chromosome, deserves specific mention because bone age findings in Turner syndrome can be misleading. Girls with Turner syndrome often have a bone age that appears only mildly delayed while their actual growth trajectory is significantly compromised, meaning standard Bayley-Pinneau predictions tend to overestimate their final adult height without syndrome-specific correction factors.

Celiac disease is worth highlighting for U.S. parents because it is frequently undiagnosed for years in American children. Untreated celiac disease causes intestinal inflammation that impairs nutrient absorption, slowing skeletal maturation and growth velocity simultaneously. Children diagnosed with celiac disease who begin a strict gluten-free diet often experience a period of catch-up growth, during which their bone age advancement temporarily exceeds their height gain before the two trajectories normalize.

What the Testing Process Looks Like for U.S. Families

Most bone age assessments in the United States follow a clear sequence that parents can anticipate before scheduling the appointment.

1. Referral: A primary care pediatrician refers the child to a pediatric endocrinologist or orders the X-ray directly when growth concerns arise, such as dropping percentile lines on a growth chart.
2. X-ray appointment: The child places their left hand flat on an imaging plate. The scan takes seconds and requires no sedation or special preparation.
3. Radiologist reading: A radiologist interprets the X-ray using the Greulich and Pyle atlas, Tanner-Whitehouse scoring, or an AI-assisted tool such as BoneXpert.
4. Endocrinologist consultation: The physician combines bone age with current height, weight, growth velocity, mid-parental height, and pubertal staging to generate a predicted adult height.
5. Follow-up imaging: If treatment is initiated or monitoring is needed, repeat bone age X-rays are typically obtained every 6 to 12 months to track skeletal maturation over time.

What to Bring to the Appointment

Parents can make the bone age evaluation more productive by arriving prepared with specific information:

• Height measurements taken at home over the past 6 to 12 months, ideally measured against a wall at consistent times of day, since children are measurably taller in the morning than in the evening due to spinal compression throughout the day.
• Heights of both biological parents, since mid-parental height calculation requires both values.
• Family history of late or early puberty, since constitutional growth delay and early puberty both have strong familial patterns.
• Records of any chronic conditions, medications, or supplements, particularly corticosteroids such as prednisone, which are known to suppress growth velocity and can delay bone age with prolonged use.
• Previous height measurements from the child’s pediatrician, which the physician can use to calculate growth velocity over time.

Understanding the Cost Without Insurance

For families without insurance coverage or facing high deductibles, a hand and wrist X-ray at a U.S. outpatient radiology center typically costs between $100 and $300 without insurance, depending on geographic location and facility type. The subsequent pediatric endocrinologist consultation typically adds $200 to $500 for an initial visit at a private practice, with academic medical center rates varying considerably. Many children’s hospitals offer financial assistance programs for families who qualify based on income.

Growth Hormone Therapy and Bone Age Monitoring

When a child is diagnosed with growth hormone deficiency, which is confirmed through stimulation testing rather than bone age alone, treatment with recombinant human growth hormone (rhGH) typically begins promptly. Bone age monitoring during therapy is remarkably important because accelerating height growth also accelerates skeletal maturation in some children.

Physicians track the ratio of height gain to bone age advancement during treatment. The goal is a ratio where height increases faster than bone age advances, which preserves the window of growth available to the child. A ratio where bone age advances faster than height gain suggests the treatment may be reducing the final adult height benefit.

The Lawson Wilkins Pediatric Endocrine Society and the American Academy of Pediatrics both recognize bone age assessment as a standard component of managing growth disorders in children across the United States.

Growth hormone therapy in the United States is approved by the Food and Drug Administration (FDA) for several specific indications beyond growth hormone deficiency, including short stature associated with Turner syndrome, Prader-Willi syndrome, chronic kidney disease, children born small for gestational age who do not show catch-up growth by age 2, and idiopathic short stature when predicted adult height falls below 5 feet 3 inches for boys and 4 feet 11 inches for girls. Bone age is a required component of the documentation for most of these FDA-approved indications when submitting for insurance authorization.

The annual cost of recombinant human growth hormone therapy in the United States ranges from approximately $10,000 to $60,000 per year depending on the child’s weight-based dose and the specific brand prescribed. Insurance coverage for growth hormone is highly variable, and prior authorization typically requires documented bone age results, growth velocity data, and IGF-1 levels.

GnRH Analog Therapy and Its Relationship to Bone Age

One treatment approach specifically designed to preserve growth potential by slowing bone age advancement is GnRH analog therapy, also called gonadotropin-releasing hormone analog therapy. These medications, which include leuprolide acetate sold under the brand name Lupron and histrelin acetate sold as Supprelin, suppress the sex hormones that drive both puberty progression and growth plate maturation.

GnRH analogs are used in two distinct clinical scenarios where bone age is central to the treatment decision:

• Precocious puberty: When a child enters puberty early, their bone age advances rapidly and growth plates begin closing years ahead of schedule. GnRH analogs pause puberty, slowing bone age advancement and allowing the child more time to grow before plates close. The goal is to preserve, and ideally improve, predicted adult height.
• Short stature with advanced bone age: In some children with significantly advanced bone age and a compromised predicted adult height, GnRH analogs are used in combination with growth hormone therapy to slow the rate of skeletal maturation while growth hormone stimulates height gain.

The effectiveness of GnRH analog therapy in improving final adult height in precocious puberty is well established in the medical literature when treatment is started before bone age reaches approximately 12 years in girls and 13 years in boys. Starting treatment after these bone age thresholds provides diminishing returns on final height outcome.

How Bone Age Interpretation Differs Across Ethnic Groups

One of the most clinically important and underappreciated limitations of current bone age methods is their differential accuracy across ethnic and racial groups. The Greulich and Pyle atlas, which remains the most commonly used reference in U.S. clinical practice, was built from data collected on a predominantly white, middle-class American population during the 1930s and 1940s.

Research published in peer-reviewed journals has documented meaningful differences in skeletal maturation timing across populations:

• African American children tend to have bone ages that are modestly advanced compared to the Greulich and Pyle reference for the same chronological age, meaning the atlas may slightly overestimate their remaining growth potential.
• Asian American children show skeletal maturation patterns that differ from the original atlas sample in ways that vary by specific ancestry and generation.
• Hispanic American children show variable patterns depending on country of family origin and generation.

These differences are generally modest in magnitude, typically in the range of 3 to 6 months of bone age, but they carry clinical relevance when a prediction is already near a treatment threshold. A child whose bone age reads 0.5 years advanced due to atlas mismatch rather than true acceleration could be misclassified as having a more compromised predicted adult height than is actually the case.

Several research groups have developed population-specific bone age reference data to address this limitation, and some academic centers now apply ethnicity-specific corrections when interpreting bone age results. Parents from non-European ancestry backgrounds should feel empowered to ask their child’s radiologist or endocrinologist whether any population-specific adjustment was applied to the reading.

Accuracy Limitations Parents Should Know

Bone age prediction is impressively useful, but it carries real limitations that every parent should understand before placing too much weight on any single number.

• Inter-observer variability: Two radiologists reading the same X-ray using the Greulich and Pyle method may produce results that differ by up to 6 months in skeletal age.
• Population bias in reference atlases: The Greulich and Pyle atlas was developed primarily from data collected on white, middle-class children in the United States during the 1930s and 1940s. Research has shown that skeletal maturation norms differ modestly across ethnic groups, which can introduce systematic error when applying this atlas to diverse populations.
• Prediction error range: Even with an accurate bone age reading, the Bayley-Pinneau method carries a prediction error of approximately plus or minus 1.5 to 2 inches at the 95% confidence level for most children.
• Puberty timing effects: Children in the early or late stages of puberty at the time of testing may have predictions that shift as puberty progresses.
• Single time-point limitation: A bone age taken at a single moment in time captures a snapshot, not a trajectory. Two bone age readings taken 6 to 12 months apart provide far more actionable information by revealing how quickly the skeleton is maturing, which is the data point that most directly drives clinical decisions.

Reading a Growth Chart Alongside Bone Age Results

Bone age results are most meaningful when placed in the context of a child’s growth chart, specifically the CDC growth charts published by the Centers for Disease Control and Prevention and the WHO growth standards used for children under age 2 in U.S. pediatric practice.

A growth chart plots a child’s height and weight as percentiles relative to a large reference population. The 3rd percentile line means the child is taller than 3% of children their age and shorter than 97%. The 50th percentile represents the population median. Pediatricians become concerned not only when a child falls below the 3rd percentile but also when a child who previously tracked along the 50th percentile drops to the 25th or 10th percentile over time, a pattern called crossing percentile lines downward that suggests growth is decelerating relative to the child’s own established trajectory.

When bone age results are available, the child’s current height can also be plotted against their bone age rather than their chronological age. A child who is short for their chronological age but average for their bone age is in a very different clinical situation than a child who is short for both. The former suggests delayed maturation with preserved growth potential; the latter may suggest a more significant growth impairment.

When to Ask Your Child’s Doctor About Bone Age Testing

Most children never need a bone age X-ray. Testing is meaningfully most useful when specific concerns arise, rather than as routine screening.

Consider asking your child’s pediatrician about bone age assessment if:

• Your child has fallen off their growth curve by crossing 2 or more major percentile lines downward on a standard CDC growth chart over any 6 to 12 month period.
• Your child is shorter than the 3rd percentile for their age and sex.
• You notice signs of puberty beginning before age 8 in a girl or 9 in a boy.
• Your child has a chronic medical condition, such as inflammatory bowel disease or celiac disease, known to affect growth.
• There is a significant discrepancy between your child’s height and the height expected from their parents’ heights.
• Your child’s growth velocity appears to have slowed or stalled based on sequential height measurements.
• Your child has been treated with corticosteroids for extended periods, since prolonged steroid use suppresses growth hormone secretion and can alter skeletal maturation timing.

Bone age testing is covered by most U.S. health insurance plans when ordered for documented growth concerns, though families should verify coverage with their specific insurer before scheduling the appointment.

The Role of IGF-1 and Other Lab Tests That Accompany Bone Age

Bone age is rarely ordered in isolation when a physician genuinely suspects a growth disorder. It is typically one component of a broader laboratory evaluation that helps distinguish among the various causes of abnormal growth patterns.

IGF-1, which stands for insulin-like growth factor 1, is a hormone produced primarily in the liver in response to growth hormone signaling. It is the most commonly used blood test for evaluating the growth hormone axis. A low IGF-1 level in a child with a delayed bone age and poor growth velocity significantly raises suspicion for growth hormone deficiency, though it is not diagnostic on its own.

IGFBP-3, or insulin-like growth factor binding protein 3, is often measured alongside IGF-1 because it carries IGF-1 in the bloodstream and provides complementary information about growth hormone secretion, particularly in very young children where IGF-1 alone may be less sensitive.

Thyroid function tests, including TSH and free T4, are almost always checked when bone age is delayed, because hypothyroidism is one of the most common treatable causes of both delayed bone age and poor growth velocity in U.S. children.

Complete blood count and metabolic panel testing helps screen for chronic diseases such as anemia, kidney disease, and liver disease, all of which can impair growth.

Karyotype testing, which analyzes chromosomal structure, is recommended for girls with unexplained short stature regardless of bone age to screen for Turner syndrome, since Turner syndrome can present without obvious physical features in some cases.

The bone age result helps prioritize which additional tests are most important. A child with a significantly advanced bone age warrants sex hormone measurements and adrenal hormone testing, while a child with a significantly delayed bone age warrants thyroid and growth hormone axis evaluation first.

Bone Age in the Context of Adopted Children

Bone age testing carries particular value for internationally adopted children coming to the United States, a population that pediatricians across the country encounter regularly. Many internationally adopted children have incomplete or unavailable birth records, making chronological age uncertain or entirely unknown.

In these situations, bone age provides the closest available estimate of biological age and growth potential. Pediatricians and adoption medicine specialists use bone age to establish an estimated chronological age, set appropriate expectations for growth, and screen for undiagnosed growth or hormonal conditions that may have gone untreated in the child’s country of origin.

Children adopted from orphanage settings frequently show bone ages that are delayed relative to their estimated chronological age, a pattern associated with psychosocial short stature or psychosocial growth delay, a condition in which emotional deprivation and chronic stress suppress growth hormone secretion even in the absence of any structural pituitary abnormality. These children often show remarkable catch-up growth after placement in a nurturing family environment, and serial bone age assessments document this recovery in a concrete, measurable way.

The Broader Picture: What Bone Age Cannot Tell You

Bone age tells you where a child’s skeleton is today relative to where it needs to be at maturity. It does not identify the cause of any difference, and it cannot account for every variable that shapes final height, including nutrition quality, sleep duration, chronic stress, or acute illness during critical growth windows.

Sleep is a particularly underappreciated factor in the height conversation. The majority of growth hormone secretion in children occurs during slow-wave sleep, specifically in the first few hours after sleep onset. Children who consistently get fewer than the 9 to 11 hours of sleep recommended by the American Academy of Sleep Medicine for school-age children and the 8 to 10 hours recommended for teenagers may be modestly limiting their own growth hormone output, an effect that bone age assessment cannot capture but that parents have direct control over.

Nutrition similarly shapes growth in ways bone age cannot quantify. Adequate intake of protein, calcium, zinc, and vitamin D is required to support the bone mineralization that converts cartilage growth plates into solid bone tissue. Vitamin D deficiency, which the CDC has identified as common in American children particularly in northern latitudes during winter months, impairs calcium absorption and can compromise bone density even when bone age and height appear relatively normal.

Growth velocity, measured by tracking height at consistent intervals over time, carries equally important diagnostic information. A child with a delayed bone age who is also growing at a normal velocity is in a very different clinical situation than a child with a delayed bone age whose growth has slowed significantly. Both data streams together give the most accurate and actionable picture of a child’s growth trajectory, which is why pediatric endocrinologists rarely rely on bone age in isolation.

The ultimate value of bone age testing lies not in producing a single number, but in giving families and physicians a shared, objective foundation for making informed decisions about monitoring, further evaluation, and treatment if needed. When combined with growth velocity data, pubertal staging, mid-parental height calculation, and appropriate laboratory testing, bone age becomes one of the most informative single tests available in pediatric medicine for understanding where a child’s growth is headed and what, if anything, needs to be done about it.

FAQs

What is bone age and how does it differ from chronological age?

Bone age, also called skeletal age, measures how mature a child’s skeleton is based on the development of growth plates in their bones. Chronological age is simply how many years a child has been alive. A child can be 10 years old chronologically but have a bone age of 8, meaning their skeleton is developing on a slower schedule than average.

How is bone age tested?

Bone age is measured using a single X-ray of the left hand and wrist. The image is compared against standard reference atlases, most commonly the Greulich and Pyle atlas, to determine how mature the bones appear relative to population averages by age and sex.

How accurate is bone age in predicting adult height?

Bone age predictions are reasonably reliable but carry a margin of error of approximately plus or minus 1.5 to 2 inches in most children. Accuracy improves when bone age is combined with current height, growth velocity, and mid-parental height calculations.

What does it mean if my child’s bone age is younger than their actual age?

A bone age younger than chronological age means the skeleton is maturing more slowly than average, which generally indicates more growth potential remains. Common causes include constitutional growth delay, growth hormone deficiency, or hypothyroidism, though some children simply mature later naturally.

What does an advanced bone age mean for my child’s height?

An advanced bone age means the growth plates are maturing faster than expected, which typically shortens the window of remaining growth. This can result in a lower predicted adult height than mid-parental calculations would suggest and may indicate precocious puberty or hormonal conditions.

At what bone age do growth plates close?

Growth plates in girls typically close when bone age reaches approximately 14 to 16 years. In boys, closure generally occurs when bone age reaches 16 to 18 years. Once plates are closed, no significant further height gain is possible.

How do doctors use bone age to calculate predicted adult height?

The most common method is the Bayley-Pinneau table, where a child’s current height is divided by a percentage value matched to their bone age and sex to estimate final adult stature. Pediatricians also use this alongside mid-parental height formulas for a more complete prediction.

Is bone age testing safe for children?

Yes. The radiation dose from a hand and wrist X-ray is approximately 0.001 millisieverts, which is less than the radiation received from a single day of normal background exposure in the environment. The test is considered very low risk.

How often should bone age be checked?

For children being monitored or treated for a growth disorder, bone age X-rays are typically repeated every 6 to 12 months. Children with no identified growth concern do not need routine bone age testing.

Can nutrition affect bone age?

Yes. Chronic malnutrition or severe caloric restriction can delay skeletal maturation, resulting in a younger bone age. Conversely, obesity has been associated with mildly advanced bone age, and deficiencies in vitamin D, zinc, and calcium can impair the bone mineralization that supports normal skeletal development.

Does bone age predict height differently for boys and girls?

Yes. The reference tables and atlases are sex-specific because boys and girls follow different skeletal maturation timelines. Girls generally reach skeletal maturity 2 to 3 years earlier than boys on average, and the Bayley-Pinneau tables account for this difference with separate columns.

Can a child’s predicted adult height change over time?

Yes, predicted adult height based on bone age can shift as new X-rays are taken and growth continues. Predictions made before puberty often carry more uncertainty than those made during mid-puberty, when the growth trajectory becomes clearer and remaining growth potential is more precisely defined.

What specialist should I see if I am concerned about my child’s bone age or growth?

A pediatric endocrinologist, a physician who specializes in hormonal and growth disorders in children, is the appropriate specialist. Your child’s primary care pediatrician can provide a referral and will typically order the initial bone age X-ray as part of the evaluation process.

Does insurance cover bone age X-rays in the United States?

Most U.S. health insurance plans, including Medicaid, cover bone age X-rays when they are ordered by a physician for documented medical indications such as short stature or suspected growth disorders. Families should confirm coverage with their insurer before the appointment to avoid unexpected costs.

Why is the left hand used instead of the right hand for bone age X-rays?

The left hand is the established standard based on the population studies used to create the Greulich and Pyle atlas and other reference tools. Using the same side as the reference data ensures the comparison is valid. For left-handed individuals or those with left hand injuries, the right hand may be used with appropriate notation.

What is constitutional growth delay and how is it different from growth hormone deficiency?

Constitutional growth delay is a normal variant in which a child matures more slowly than average, has a delayed bone age, but is otherwise healthy and will reach a normal adult height without treatment. Growth hormone deficiency is a medical condition in which the pituitary gland does not produce adequate growth hormone, requiring treatment. Both present with delayed bone age and slow growth velocity, and distinguishing between them requires growth hormone stimulation testing rather than bone age alone.

Can GnRH analogs improve my child’s final adult height?

GnRH analogs can improve predicted adult height in children with precocious puberty by slowing bone age advancement and preserving the growth window. The benefit is greatest when treatment begins before bone age reaches approximately 12 years in girls and 13 years in boys. Their effectiveness for improving height in children without precocious puberty is more variable and should be discussed in detail with a pediatric endocrinologist.

How does sleep affect a child’s growth and bone age?

The majority of growth hormone secretion occurs during slow-wave sleep in the first few hours after sleep onset. Children who consistently sleep fewer than the recommended 9 to 11 hours per night for school-age children may be limiting their own growth hormone output. Sleep quality and duration do not directly appear on a bone age X-ray but can meaningfully influence overall growth trajectory over time.

How is bone age used for children with unknown birth dates, such as internationally adopted children?

Bone age provides the closest available biological estimate of age when birth records are unavailable. Adoption medicine specialists and pediatricians use bone age to establish an estimated chronological age, set growth expectations, and screen for previously undiagnosed conditions. Many internationally adopted children show delayed bone age related to prior neglect or malnutrition, and serial assessments can document catch-up growth after placement.

Are AI-based bone age tools more accurate than traditional atlas methods?

AI-assisted tools such as BoneXpert have demonstrated lower inter-observer variability than traditional manual atlas comparison in published research, meaning their readings are more consistent across different clinical settings and readers. However, AI tools are not yet universally available across U.S. radiology departments, and their performance across diverse ethnic populations continues to be evaluated in ongoing research.

What blood tests are typically ordered alongside a bone age X-ray?

When a growth disorder is suspected, bone age is typically accompanied by IGF-1, IGFBP-3, TSH, free T4, a complete blood count, and a comprehensive metabolic panel at minimum. Girls with unexplained short stature should also have a karyotype to screen for Turner syndrome. The specific panel ordered depends on the clinical picture and which direction the bone age result points.